Business Description
Zynex Inc
NAICS : 423460
SIC : 5122
Compare
Compare
Traded in other countries / regions
ZYXI.USA
Description
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufacture, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. it also develops and markets medical devices for non-invasive cardiac monitoring, the products of which are under development. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave and others.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.87 | |||||
| Equity-to-Asset | 0.58 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | 1.08 | |||||
| Interest Coverage | 92.51 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 6.62 | |||||
| Beneish M-Score | 3.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 57.4 | |||||
| 3-Year EBITDA Growth Rate | 29.6 | |||||
| 3-Year EPS without NRI Growth Rate | 19.9 | |||||
| 3-Year FCF Growth Rate | -10 | |||||
| 3-Year Book Growth Rate | 91.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 35.81 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.75 | |||||
| 9-Day RSI | 48.91 | |||||
| 14-Day RSI | 49.81 | |||||
| 6-1 Month Momentum % | 43.5 | |||||
| 12-1 Month Momentum % | -13.66 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.75 | |||||
| Quick Ratio | 2.98 | |||||
| Cash Ratio | 1.43 | |||||
| Days Inventory | 148.9 | |||||
| Days Sales Outstanding | 64.76 | |||||
| Days Payable | 56.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.8 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 80.14 | |||||
| Operating Margin % | 18.11 | |||||
| Net Margin % | 13.79 | |||||
| ROE % | 29.05 | |||||
| ROA % | 17.63 | |||||
| ROIC % | 30.04 | |||||
| ROC (Joel Greenblatt) % | 56.11 | |||||
| ROCE % | 27.31 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 18.32 | |||||
| Forward PE Ratio | 17.12 | |||||
| PE Ratio without NRI | 18.32 | |||||
| Shiller PE Ratio | 79.72 | |||||
| Price-to-Owner-Earnings | 40.31 | |||||
| PEG Ratio | 0.3 | |||||
| PS Ratio | 2.53 | |||||
| PB Ratio | 5.05 | |||||
| Price-to-Tangible-Book | 8.89 | |||||
| Price-to-Free-Cash-Flow | 28.98 | |||||
| Price-to-Operating-Cash-Flow | 27.99 | |||||
| EV-to-EBIT | 13.56 | |||||
| EV-to-EBITDA | 12.29 | |||||
| EV-to-Revenue | 2.46 | |||||
| EV-to-Forward-Revenue | 1.76 | |||||
| EV-to-FCF | 28.57 | |||||
| Price-to-Projected-FCF | 2.79 | |||||
| Price-to-Median-PS-Value | 1.43 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.74 | |||||
| Price-to-Graham-Number | 2.69 | |||||
| Price-to-Net-Current-Asset-Value | 17.44 | |||||
| Earnings Yield (Greenblatt) % | 7.37 | |||||
| Forward Rate of Return (Yacktman) % | 21.68 |
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ZYXI
Executives
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 142.994 | ||
| EPS (TTM) ($) | 0.495 | ||
| Beta | 0.42 | ||
| Volatility % | 40.84 | ||
| 14-Day RSI | 49.81 | ||
| 14-Day ATR ($) | 0.514091 | ||
| 20-Day SMA ($) | 9.1235 | ||
| 12-1 Month Momentum % | -13.66 | ||
| 52-Week Range ($) | 4.97 - 14.236363 | ||
| Shares Outstanding (Mil) | 38.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zynex Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zynex Inc Analysis
Share your researchHeadlines
See More
No news.